The Effect of Fluvoxamine and Behavior Therapy on Children and Adolescents with Obsessive-Compulsive Disorder
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The efficacy of medications, consisting of serotonin partial and specific reuptake blockers, and behavior therapy, consisting of exposure and response prevention in addition to social skills training, cognitive therapy, and habit reversal, in the treatment of obsessive-compulsive disorder are well documented. The purpose of the study was to explore if adding behavior therapy to medication would enhance treatment efficacy. METHODS: Ten children/adolescents who had not previously responded to behavior therapy were randomly assigned to two groups: fluvoxamine alone or fluvoxamine with behavior therapy. All 10 patients received fluvoxamine for 10 weeks-five continued solely on fluvoxamine for one year and five engaged in behavior therapy for 20 sessions along with fluvoxamine and then continued solely on medication until the end of the year. RESULTS: Eight of 10 patients improved significantly on fluvoxamine at week 10 on the primary outcome variable, the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). According to the other measurements-National Institute of Mental Health-Global Obses-sive-Compulsive Scale, Clinical Global Impression-Improvement (assessing level of im-provement from week to week), and Clinical Global Impression-Severity of Illness Scale (as-sessing how ill the patient is from week to week)-improvement was not as evident. According to the CY-BOCS, those who received a combination of fluvoxamine and exposure with response prevention showed significantly more improvement than those who only took medication. At two-year follow-up, all patients continued to improve, with those in the combined approach improving more than those in the medication-alone group. CONCLUSIONS: Future studies should determine the specific effect of each treatment group, combined and singularly. Reasons for discrepancy in improvement ratings as noted by the different instruments are discussed. The addition of behavior therapy to fluvoxamine seems to enhance treatment efficacy, according to the CY-BOCS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stein, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09620-4 · Cited by 352
Psychopharmacology Interventions for Pediatric Anxiety Disorders: A Research Update
Waslick, B. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.009 · Cited by 17
“Preliminary attempts to compare psychosocial treatment strategies (ie, cognitive behavior therapy, CBT) with medication treatment and combination treatments have been difficult to interpret because of small sample sizes, lack of suitable control conditions, and lack of appropriate blinding of evaluators providing the…”
BackgroundTeunisse, A. K., Pembroke, L., O’Gradey‐Lee, M., Sy, M., Rapee, R. M., Wuthrich, V. M., Creswell, C., & Hudson, J. L. (2022) · JCPP Advances · doi:10.1002/jcv2.12080 · Cited by 15
Metadata
- Authors
- NEZIROGLU, F., YARYURA-TOBIAS, J. A., WALZ, J., & McKAY, D.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2000-01
- Volume
- 10
- Issue
- 4
- Pages
- 295-306
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2020183127
- Cited by
- 59
- References
- 0
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Fluvoxamine and Behavior Therapy on Children and Adolescents with Obsessive-Compulsive Disorder. https://app.cochat.ai/papers/10.1089/cap.2000.10.295
- The paper
- NEZIROGLU, F., YARYURA-TOBIAS, J. A., WALZ, J., & McKAY, D. (2000). The Effect of Fluvoxamine and Behavior Therapy on Children and Adolescents with Obsessive-Compulsive Disorder. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2000.10.295
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.